These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Photodynamic cell-kill analysis of breast tumor cells with a tamoxifen-pyropheophorbide conjugate. Fernandez Gacio A; Fernandez-Marcos C; Swamy N; Dunn D; Ray R J Cell Biochem; 2006 Oct; 99(3):665-70. PubMed ID: 16795032 [TBL] [Abstract][Full Text] [Related]
6. Combinatorial chemistry in steroid receptor drug discovery. Flygare JA; Sutherlin DP; Brown SD Methods Mol Biol; 2001; 176():353-8. PubMed ID: 11554335 [No Abstract] [Full Text] [Related]
7. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions. Jordan VC J Med Chem; 2003 Mar; 46(6):883-908. PubMed ID: 12620065 [No Abstract] [Full Text] [Related]
8. An expeditious synthesis of tamoxifen, a representative SERM (selective estrogen receptor modulator), via the three-component coupling reaction among aromatic aldehyde, cinnamyltrimethylsilane, and beta-chlorophenetole. Shiina I; Sano Y; Nakata K; Suzuki M; Yokoyama T; Sasaki A; Orikasa T; Miyamoto T; Ikekita M; Nagahara Y; Hasome Y Bioorg Med Chem; 2007 Dec; 15(24):7599-617. PubMed ID: 17904372 [TBL] [Abstract][Full Text] [Related]
9. A molecular docking study of estrogenically active compounds with 1,2-diarylethane and 1,2-diarylethene pharmacophores. Kekenes-Huskey PM; Muegge I; von Rauch M; Gust R; Knapp EW Bioorg Med Chem; 2004 Dec; 12(24):6527-37. PubMed ID: 15556769 [TBL] [Abstract][Full Text] [Related]
10. On-line formation, separation, and estrogen receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators. van Liempd SM; Kool J; Niessen WM; van Elswijk DE; Irth H; Vermeulen NP Drug Metab Dispos; 2006 Sep; 34(9):1640-9. PubMed ID: 16790557 [TBL] [Abstract][Full Text] [Related]
12. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. Jordan VC; O'Malley BW J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378 [TBL] [Abstract][Full Text] [Related]
13. [Modern approaches to estrogen-independent growth of breast tumor]. Krasil'nikov MA Vopr Onkol; 2004; 50(4):399-405. PubMed ID: 15605761 [No Abstract] [Full Text] [Related]
14. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance. Lewis JS; Jordan VC Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919 [TBL] [Abstract][Full Text] [Related]
15. [Selective estrogen receptor modulators: mechanisms of action and their tissue selectivity]. Azuma K; Inoue S Clin Calcium; 2004 Oct; 14(10):12-26. PubMed ID: 15577127 [TBL] [Abstract][Full Text] [Related]
16. QSAR of estrogen receptor modulators: exploring selectivity requirements for ER(alpha) versus ER(beta) binding of tetrahydroisoquinoline derivatives using E-state and physicochemical parameters. Mukherjee S; Saha A; Roy K Bioorg Med Chem Lett; 2005 Feb; 15(4):957-61. PubMed ID: 15686893 [TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators. Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115 [TBL] [Abstract][Full Text] [Related]